781675-14-7

Basic information

• Product Name: Propanamide, N-[5-[[[(3-aminopropyl)sulfonyl]amino]methyl]-4-(2,2-dimethyl-1-oxoprop yl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-
• CAS NO: 781675-14-7
• Molecular Formula: C22H35N5O4S2
• Molecular Weight: 497.683
• Mol File: 781675-14-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Propanamide, N-[5-[[[(3-aminopropyl)sulfonyl]amino]methyl]-4-(2,2-dimethyl-1-oxoprop yl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanamide, N-[5-[[[(3-aminopropyl)sulfonyl]amino]methyl]-4-(2,2-dimethyl-1-oxoprop yl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-(781675-14-7)
• EPA Substance Registry System: Propanamide, N-[5-[[[(3-aminopropyl)sulfonyl]amino]methyl]-4-(2,2-dimethyl-1-oxoprop yl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-(781675-14-7)

Safety Data

• Hazardous Substances Data: 781675-14-7(Hazardous Substances Data)

Upstream product

• 76477-26-4 (2-Oxo-2-phenylethyl)carbamic acid tert-butyl ester 
• 781675-12-5 N-[5-(3-chloropropanesulfonylaminomethyl)-4-(2,2-dimethylpropionyl)-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide 
• 314773-77-8 tert-butyl (2-acetylphenyl)carbamate 
• 25384-14-9 2-aminoacetophenone hydrochloride 
• 910634-47-8 [3-(2,2-dimethylpropionyl)-5-(2,2-dimethylpropionylamino)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-ylmethyl]carbamic acid tert-butyl ester 
• 781675-01-2 [3-(2,2-dimethylpropionyl)-5-(2,2-dimethylpropionylamino)-2-phenyl-2,3-dihydro-1,3, 4-thiadiazol-2-ylmethyl]carbamic acid tert-butyl ester 

Relevant articles and documents

AGENT FOR TREATMENT OF HEMATOPOIETIC TUMOR

A therapeutic and/or prophylactic agent for a hematopoietic tumor, which comprises a thiadiazoline derivative represented by the general formula (I), or a pharmaceutically acceptable salt thereof: [wherein, n represents an integer of 1 to 3, R1

M-STAGE KINESIN INHIBITOR

A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein R1 represents a hydrogen atom and the like, R2 represents a hydrogen atom, -C(=W)R6 (wherein W represents an oxygen atom or a sulfur atom, and R6 represents substituted or unsubstituted lower alkyl and the like) and the like, R3 represents -C(=Z)R19 (wherein Z represents an oxygen atom or a sulfur atom, and R19 represents substituted or unsubstituted lower alkyl and the like) and the like, R4 represents substituted or unsubstituted lower alkyl and the like, and R5 represents substituted or unsubstituted aryl and the like] and the like are provided.